1. Home
  2. MOLN vs CLAR Comparison

MOLN vs CLAR Comparison

Compare MOLN & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molecular Partners AG

MOLN

Molecular Partners AG

N/A

Current Price

$4.10

Market Cap

164.2M

Sector

N/A

ML Signal

N/A

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$3.61

Market Cap

129.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOLN
CLAR
Founded
2004
1957
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
164.2M
129.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MOLN
CLAR
Price
$4.10
$3.61
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$3.75
$5.33
AVG Volume (30 Days)
4.7K
149.3K
Earning Date
02-11-2026
11-06-2025
Dividend Yield
N/A
2.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$256,432,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$999.99
$3.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.36
$3.02
52 Week High
$5.91
$5.08

Technical Indicators

Market Signals
Indicator
MOLN
CLAR
Relative Strength Index (RSI) 47.93 62.97
Support Level $4.21 $3.39
Resistance Level $4.48 $3.40
Average True Range (ATR) 0.16 0.11
MACD -0.02 0.02
Stochastic Oscillator 18.75 79.22

Price Performance

Historical Comparison
MOLN
CLAR

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: